Hickory Point Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Hickory Point Bank & Trust's BMY Position: Q2 2026 in Review
Hickory Point Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,795 shares worth $276K. The position accounts for 0.17% of the portfolio, ranked #109.
Hickory Point Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $397K in Q4 2024. 874 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hickory Point Bank & Trust held 4,795 shares of Bristol-Myers Squibb worth $276K as of Q2 2026.
- Hickory Point Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.17% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #109 holding.
- Hickory Point Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Hickory Point Bank & Trust's Bristol-Myers Squibb position peaked at $397K in Q4 2024.
- 874 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.